Fresenius Medical Care AG (FMS): Price and Financial Metrics

Fresenius Medical Care AG (FMS): $30.37

0.17 (+0.56%)

POWR Rating

Component Grades














  • FMS scores best on the Stability dimension, with a Stability rank ahead of 98.57% of US stocks.
  • FMS's strongest trending metric is Quality; it's been moving down over the last 179 days.
  • FMS's current lowest rank is in the Momentum metric (where it is better than 17.16% of US stocks).

FMS Stock Summary

  • With a market capitalization of $19,654,731,060, Fresenius Medical Care AG & Co KGaA has a greater market value than 87.43% of US stocks.
  • For FMS, its debt to operating expenses ratio is greater than that reported by 77.84% of US equities we're observing.
  • Revenue growth over the past 12 months for Fresenius Medical Care AG & Co KGaA comes in at -7.51%, a number that bests only 11.93% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Fresenius Medical Care AG & Co KGaA, a group of peers worth examining would be ICL, JKS, AXTA, UUU, and PPG.
  • Visit FMS's SEC page to see the company's official filings. To visit the company's web site, go to

FMS Valuation Summary

  • FMS's price/sales ratio is 1.3; this is 88.55% lower than that of the median Healthcare stock.
  • FMS's price/earnings ratio has moved up 12.4 over the prior 243 months.
  • FMS's price/sales ratio has moved up 0.8 over the prior 243 months.

Below are key valuation metrics over time for FMS.

Stock Date P/S P/B P/E EV/EBIT
FMS 2021-08-31 1.3 2.0 19.4 16.3
FMS 2021-08-30 1.3 2.0 19.5 16.4
FMS 2021-08-27 1.3 2.0 19.6 16.4
FMS 2021-08-26 1.3 2.1 19.9 16.6
FMS 2021-08-25 1.3 2.1 19.9 16.6
FMS 2021-08-24 1.3 2.1 20.2 16.8

FMS Growth Metrics

    Its 3 year cash and equivalents growth rate is now at 68.83%.
  • Its 3 year price growth rate is now at -3.5%.
  • The 2 year revenue growth rate now stands at -7.66%.
Over the past 18 months, FMS's revenue has gone down $1,207,128,221.

The table below shows FMS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 20,021.23 2,489.498 1,101.486
2021-09-30 20,199.78 2,404.636 1,067.152
2021-06-30 20,404.96 2,458.608 1,174.364
2021-03-31 21,182.4 3,856.737 1,362.173
2020-12-31 21,647.35 4,233.156 1,411.366
2020-09-30 21,222.2 4,419.68 1,564.352

FMS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • FMS has a Quality Grade of B, ranking ahead of 82.76% of graded US stocks.
  • FMS's asset turnover comes in at 0.553 -- ranking 46th of 81 Healthcare stocks.
  • 500 - Internal server error

The table below shows FMS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2020-12-31 0.553 0.310 0.091
2019-12-31 0.591 0.309 0.117
2018-12-31 0.658 0.312 0.236
2018-12-31 0.658 0.312 0.236
2017-12-31 0.698 0.338 0.154
2016-12-31 0.683 0.323 0.155

FMS Stock Price Chart Interactive Chart >

Price chart for FMS

FMS Price/Volume Stats

Current price $30.37 52-week high $42.45
Prev. close $30.20 52-week low $28.75
Day low $30.20 Volume 275,753
Day high $30.50 Avg. volume 507,239
50-day MA $32.05 Dividend yield 1.62%
200-day MA $33.55 Market Cap 17.80B

Fresenius Medical Care AG (FMS) Company Bio

Fresenius Medical Care provides dialysis care services related to the dialysis treatment a patient receives with end stage renal disease, and other health care services. The company was founded in 1996 and is based in Bad Homburg, Germany.

FMS Latest News Stream

Event/Time News Detail
Loading, please wait...

FMS Latest Social Stream

Loading social stream, please wait...

View Full FMS Social Stream

Latest FMS News From Around the Web

Below are the latest news stories about Fresenius Medical Care AG & Co KGaA that investors may wish to consider to help them evaluate FMS as an investment opportunity.

Is it Still Worthy to Keep Your Fresenius Medical Care (FMS) Shares?

Artisan Partners, a high value-added investment management firm, published its ‘Artisan International Value Fund’ fourth quarter 2021 investor letter – a copy of which can be downloaded here.

Insider Monkey | February 23, 2022

DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care published form 20-F for the fiscal year 2021

DGAP-News: Fresenius Medical Care AG Co. KGaA / Key word(s): Annual Report Fresenius Medical Care AG Co. KGaA: Fresenius Medical Care published form 20-F for the fiscal year 2021 23.02.2022 / 10:30 The issuer is solely

BORSE ONLINE | February 23, 2022

Fresenius Medical (FMS) Q4 Earnings Beat Estimates, Up Y/Y

Fresenius Medical's (FMS) fourth-quarter earnings benefit from strong performance across all the geographic regions and segments.

Yahoo | February 23, 2022

Fresenius Medical Care Non-GAAP EPS of €0.90, revenue of €4.64B

Fresenius Medical Care press release (NYSE:FMS): Q4 Non-GAAP EPS of €0.90. Revenue of €4.64B (+5.5% Y/Y). Company expects revenue and net income to grow at low to mid-single digit percentage rates in FY 2022...

Seeking Alpha | February 22, 2022

Fresenius Medical Care AG & Co. KGaA. (FMS) CEO Rice Powell on Q4 2021 Results - Earnings Call Transcript

Fresenius Medical Care AG & Co. KGaA. (FMS) Q4 2021 Earnings Conference Call February 22, 2022, 09:00 AM ET Company Participants Dominik Heger - Head of Investor Relations Rice Powell - Chief Executive Officer & Chairman of the Management Board Helen Giza - Chief Financial Officer & Chief Transformation Officer,...

SA Transcripts on Seeking Alpha | February 22, 2022

Read More 'FMS' Stories Here

FMS Price Returns

1-mo -1.58%
3-mo -5.55%
6-mo 2.68%
1-year -23.78%
3-year -16.78%
5-year -30.67%
YTD -4.85%
2021 -20.79%
2020 14.17%
2019 15.01%
2018 -37.85%
2017 25.49%

FMS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full FMS Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8123 seconds.